Human Thiopurine Methyltransferase Pharmacogenetics. Kindred With a Terminal Exon Splice Junction Mutation That Results in Loss of Activity.

Journal of Clinical Investigation - United States
doi 10.1172/jci1004
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

A Single Point Mutation Leading to Loss of Catalytic Activity in Human Thiopurine S-Methyltransferase.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Thiopurine S-Methyltransferase Pharmacogenetics: Autophagy as a Mechanism for Variant Allozyme Degradation

Pharmacogenetics and Genomics
Molecular MedicineGeneticsMolecular Biology
2008English

Thiopurine Metabolites and the Role of Thiopurine Methyltransferase Activity in Inflammatory Bowel Disease

Gut
Gastroenterology
2002English

Mutation in an Intervening Sequence Splice Junction in Man.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Exon Junction Complexes Suppress Spurious Splice Sites to Safeguard Transcriptome Integrity

Molecular Cell
Cell BiologyMolecular Biology
2018English

A Novel Splice Site Mutation inSMARCAL1results in Aberrant Exon Definition in a Child With Schimke Immunoosseous Dysplasia

American Journal of Medical Genetics, Part A
Genetics
2015English

Azathioprine Therapy in Multiple Sclerosis: Phosphoribosylated Metabolites and Thiopurine Methyltransferase Activity

The Open Neuroscience Journal
2014English

Clinical Pharmacogenomics of Thiopurine S-Methyltransferase

Current Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2006English

The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs

Molecular Pharmacology
Molecular MedicinePharmacology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy